profit from every ₹100 of sales.
₹0₹100
Entero Healthcare Solutions
₹2,004.60-5.22% today
+100.8% in 1 year
1-year low ₹949.801-year high ₹2,114.90
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹75.91 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Entero Healthcare Solutions sold, what it kept, and what it did with the cash.
Sales went from ₹32.9 billion in 2023 to ₹65.9 billion in 2026, with ₹1.15 billion of profit last year.
SalesProfit
Entero Healthcare Solutions vs. similar companies
Entero Healthcare Solutions grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Entero Healthcare Solutions | 75.9× · Very expensive | ||
 McKesson | 26.2× · Fair price | ||
 Cencora | 43.0× · Expensive | ||
 Cardinal Health | 41.1× · Expensive | ||
 Sigma Healthcare | 63.4× · Very expensive |
AI analysis
An AI analyst reads Entero Healthcare Solutions's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 32,931 | 38,882 | 50,958 | 65,912 | |
| 2,613 | 3,178 | 4,863 | 6,804 | |
| 398 | 868 | 1,409 | 2,227 | |
| 649 | 1,211 | 2,111 | 2,770 | |
| -116 | 391 | 948 | 1,150 | |
| -2.66 | 10.81 | 21.76 | – | |
| 7.9% | 8.2% | 9.5% | 10.3% | |
| 1.2% | 2.2% | 2.8% | 3.4% | |
| -0.4% | 1.0% | 1.9% | 1.7% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 13,087 | 23,450 | 27,025 | 36,003 |
| Cash | 254 | 1,476 | 2,293 | 1,469 |
| Total debt | 4,378 | 3,380 | 3,852 | 6,772 |
| Total liabilities | 7,111 | 7,036 | 9,322 | 18,477 |
| 5,950 | 16,381 | 17,241 | 16,886 | |
| 43 | 36 | 44 | – | |
| 3.1% | 3.8% | 6.8% | 7.8% | |
| -1.9% | 2.4% | 5.5% | 6.8% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| -453 | -366 | -769 | 962 | |
| 55 | 54 | 113 | 675 | |
| -508 | -420 | -882 | 287 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 18 | 35 | 36 |
Valuation
- 75.9×
- –
- –
- 2.9×
- 1.3×
- 304.7×
- 33.4×
- 0.3%
- 1.3%
- –
Profitability
- 10.3%
- 3.4%
- 1.7%
- –
- 7.4%
- 5.1%
- –
- –
- –
- –
Growth
- +26.0%
- –
- –
- –
- +0.1%
Financial health
- 1.9×
- 0.40
- –
- 4.3×
- 1.58
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 41%of 958
Bottom 33%of 888
Bottom 14%of 600
Top 21%of 889
Bottom 41%of 987
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
20No pass
Benjamin Graham
21No pass
Philip Fisher
27No pass
Peter Lynch
75Pass
Joel Greenblatt
4No pass
Charlie Munger
14No pass
Terry Smith
14No pass
Questions about Entero Healthcare Solutions
Is Entero Healthcare Solutions a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Entero Healthcare Solutions AI analysis
What does Entero Healthcare Solutions do?
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. It is in Medical Distribution, based in Mumbai, India.
Is Entero Healthcare Solutions stock halal?
Yes. Entero Healthcare Solutions passes our halal screen: its business is permitted and its debt is 8% of its market value, under the 30% limit. How we check
How has Entero Healthcare Solutions stock done over the past year?
Up 100.8% over the past twelve months, to ₹2,004.60. It traded between ₹949.80 and ₹2,114.90 and is 5.2% below its high.
Who are Entero Healthcare Solutions's competitors?
The largest listed companies in the same industry are McKesson, Cencora, Cardinal Health and Sigma Healthcare. The peers table on this page compares their profit, growth and price with Entero Healthcare Solutions's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.